is development stage company that is creatingspecial purpose nanomaterials for viral therapy. This is completely novel approach that is provingto be superior to existing approaches. Actual events could differ materially andsubstantially from those projected herein and depend on number offactors including the success of the Companys research anddevelopment strategy, the availability of adequate financing, thesuccessful and timely completion of clinical studies and theuncertainties related to the regulatory process. NanoViricides, Inc. Announces New Chief RegulatoryOfficer. The Importance Of Viruses Has Demanded Fresh Appreciation In Recent Years, New Study...NanoViricides, Inc.

Announces Leasing of New R&D Facilities and Corporate Headquarters. Edot. com, Inc. Releases CEO Letter to ShareholdersTuesday 14, 2005. NanoViricides, Inc. We have over 2,000,000 cash on hand. Just the Financial Times had as itslead story that Citigroup is expanding its research and its Director ofInvestment Research said the important task for analysts wasto produce quality research, such as thematic reports on bird flu.... Begins Rabies Animal Study. NanoViricides, Inc. is development stage company that is creatingspecial purpose nanomaterials for viral therapy. Forwardlooking statements involverisks and uncertainties. Dr Seymour continued, NanoViricides at this timeis strong. Presents at the Global PharmaR&D Summit.

Actual events could differ materially andsubstantially from those projected herein and depend on number offactors including the success of the Companys research anddevelopment strategy, the availability of adequate financing, thesuccessful and timely completion of clinical studies and theuncertainties related to the regulatory process. NanoViricides, Inc. Just the Financial Times had as itslead story that Citigroup is expanding its research and its Director ofInvestment Research said the important task for analysts wasto produce quality research, such as thematic reports on bird flu.... is development stage company that is creatingspecial purpose nanomaterials for viral therapy.

Presents at the Global PharmaR&D Summit. Chiron Updates Delivery Expectations for H5N1 Vaccine Stockpile Contract. BioSante Pharmaceuticals Presents CaPadjuvanted BirdFlu Vaccine Data at Vaccine...Edot. com, Inc. Announces Leo Ehrlich asCFO. Presidio Pharmaceuticals Licenses Nuclear Exclusion Compounds from Cytokine PharmaSciences. NanoViricides, Inc. Receives Additional SafetyData.. Dr. Eugene Seymour, CEO, further added, We believe that ourbusiness plan is sound. Forwardlooking statements involverisks and uncertainties. Dr Seymour continued, NanoViricides at this timeis strong. Announces Term Sheet to AcquireNanoViricide, Inc. NanoViricides, Inc. NanoViricide drugs are designed to blockand dismantle the virus particles before they can infect cell, therebycontrolling viremia. We have over 2,000,000 cash on hand.